Sanofi Expands Hyderabad Pharma Global Capability Centre to 5 Lakh Sq Ft
In a significant development that underscores Hyderabad's rising prominence as a global hub for pharmaceutical innovation, Sanofi Healthcare India has announced a major expansion of its Global Capability Centre (GCC) in the city. The facility has been enlarged by an additional 2.7 lakh square feet, bringing the total area to approximately 5 lakh square feet. This expansion is a key component of Sanofi's broader commitment to invest Euro 400 million in its Hyderabad operations by 2030.
Boost in Employment and Strategic Positioning
The expansion will substantially increase the workforce capacity at the Hyderabad GCC, elevating it from an initially projected 2,600 employees to a range of 4,500 to 5,000. This enhancement positions Sanofi's GCC as one of the top three largest pharmaceutical GCCs in India. Notably, it becomes the second largest in Hyderabad, following the Swiss giant Novartis's GCC, which accommodates around 9,000 personnel and is located nearby.
Evolution and Technological Focus
Originally inaugurated in HiTec City in 2024, the Hyderabad GCC has evolved significantly since its inception in 2019. Initially focused on medical services, it has expanded to support end-to-end global processes for Sanofi's worldwide functions and affiliates. The centre now houses advanced capabilities across multiple cutting-edge domains, including:
- Artificial Intelligence (AI) for drug discovery and healthcare solutions
- Digital Health initiatives to enhance patient care
- Intelligent Automation to streamline operations
This technological integration reflects a strategic shift towards high-value digital and scientific innovation in the life sciences sector.
Government Endorsement and Economic Impact
Chief Minister Revanth Reddy highlighted that this expansion aligns with the state's vision to establish itself as a global leader in innovation-driven life sciences. He emphasized that it contributes to high-skilled employment opportunities, strengthens digital and scientific advancements, and positions the state among the foremost life sciences ecosystems globally.
IT Minister Sridhar Babu, who inaugurated the expanded facility, underscored Hyderabad's transformation from a traditional manufacturing base to a strategic digital hub for global biopharma. He stated, "With deep capabilities in AI, data analytics, medical affairs, and enterprise operations, this represents the next generation of value creation in life sciences." This move is expected to bolster Hyderabad's reputation as a preferred destination for pharmaceutical and technology investments, driving economic growth and innovation in the region.
